Lincoln National Corp Dexcom Inc Transaction History

Lincoln National Corp

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 01, 2024	BUY	$114.22 - $140.1 $84,865 - $104,094	743 Added 41.42%	2,537 $351,000
Q4 2023 Feb 06, 2024	SELL	$75.49 - $124.16 $38,575 - $63,445	-511 Reduced 22.17%	1,794 $222,000
Q3 2023 Nov 03, 2023	SELL	$86.06 - $137.93 $1,893 - $3,034	-22 Reduced 0.95%	2,305 $215,000
Q2 2023 Aug 04, 2023	BUY	$112.47 - $130.98 $10,684 - $12,443	95 Added 4.26%	2,327 $299,000
Q1 2023 May 01, 2023	BUY	$104.0 - $122.92 $10,712 - $12,660	103 Added 4.84%	2,232 $259,000
Q4 2022 Feb 07, 2023	BUY	$84.98 - $122.67 $180,922 - $261,164	2,129 New	2,129 $241,000
Q2 2022 Aug 02, 2022	SELL	$67.99 - $132.89 $34,470 - $67,375	-507 Closed	0 $0
Q3 2021 Nov 05, 2021	BUY	$106.71 - $143.18 $213 - $286	2 Added 0.4%	507 $277,000
Q2 2021 Aug 13, 2021	BUY	$80.99 - $107.93 $40,899 - $54,504	505 New	505 $216,000

1,014

351M

5.51M

5.6M

Ticker DXCM
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 386,257,984
Market Cap $31.1B
Description
DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...

Get notified when there are updates to the investment portfolio of Lincoln National Corp, based on Form 13F filings with the SEC.

Stay updated on Lincoln National Corp with notifications on news.